ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 53 filers reported holding ETON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $331,106 | +19.5% | 79,402 | 0.0% | 0.00% | – |
| Q2 2023 | $277,113 | -9.4% | 79,402 | 0.0% | 0.00% | – |
| Q1 2023 | $305,698 | +37.4% | 79,402 | +0.7% | 0.00% | – |
| Q4 2022 | $222,419 | +34.8% | 78,872 | 0.0% | 0.00% | – |
| Q3 2022 | $165,000 | -20.3% | 78,872 | 0.0% | 0.00% | – |
| Q2 2022 | $207,000 | -40.2% | 78,872 | -0.7% | 0.00% | – |
| Q1 2022 | $346,000 | +1.5% | 79,455 | 0.0% | 0.00% | – |
| Q4 2021 | $341,000 | -15.0% | 79,455 | -0.3% | 0.00% | – |
| Q3 2021 | $401,000 | +389.0% | 79,725 | +500.6% | 0.00% | – |
| Q2 2021 | $82,000 | -75.3% | 13,275 | -70.8% | 0.00% | – |
| Q1 2021 | $332,000 | -10.5% | 45,387 | -0.6% | 0.00% | – |
| Q4 2020 | $371,000 | +38.4% | 45,647 | +34.8% | 0.00% | – |
| Q3 2020 | $268,000 | +47.3% | 33,869 | +0.9% | 0.00% | – |
| Q2 2020 | $182,000 | – | 33,554 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,430,270 | $10,134,226 | 3.30% |
| Westside Investment Management, Inc. | 528,310 | $2,203,060 | 0.63% |
| Acuitas Investments, LLC | 219,000 | $913,230 | 0.54% |
| EAM Investors, LLC | 256,623 | $1,070,118 | 0.21% |
| Parkman Healthcare Partners LLC | 165,000 | $688,050 | 0.13% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 110,016 | $458,767 | 0.08% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 300,000 | $1,251,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 271,462 | $1,131,997 | 0.03% |
| Quantum Private Wealth, LLC | 11,500 | $47,955 | 0.02% |
| CHICAGO TRUST Co NA | 16,700 | $69,639 | 0.02% |